Medpace Stock Plunges 16% as Securities Lawsuit Alleges Guidance Misstatements
Robbins Geller files class action against $MEDP over alleged false book-to-bill projections. Stock fell 16% after Q4 miss. Lead plaintiff deadline: June 8, 2026.
MEDPsecurities fraudclass action lawsuit